Rahul Saxena

TL;DR: In this article, an industrially advantageous process for the preparation of ezetimibe of formula (I) in high yields by using novel benzyl ester intermediates was proposed.

TL;DR: In this article, an improved process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile of Formula (Structure 2) was described.

TL;DR: In this paper, an improved process for the preparation of ranolazine of formula I and pharmaceutically acceptable salts thereof, by reacting 2,6-dimethylaniline derivative with chloroacetyl chloride in the presence of base in water and resulting amide intermediate is reacted with piperazine and the resulting piperazinc derivative is further condensed with an appropriate oxirane derivative.

TL;DR: In this article, the title compound, C24H21F2NO2, has a T-shaped form in the crystal structure and the central tetra-hydro-pyran ring shows a chair conformation.